Siri Drugs India Private Limited - Company Profile

It is a pharma private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2012.
2012 Visakhapatnam, Andhra Pradesh, India Amalgamated
Last Updated:
Access Report
About Siri Drugs India Private Limited

Siri Drugs India Private Limited, a amalgamated private limited company, was established on 24 February 2012 in Visakhapatnam, Andhra Pradesh, India. Engaging in api manufacturers within the pharma sector, it holds CIN: U24232AP2012PTC079367. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹16.00 Cr and a paid-up capital of ₹7.34 Cr.

Its leadership includes Teena Tummuri (Additional Director), Pamidi Ravindra (Director), Prasanth Nandigala (Director). Past directors included Sarath Kumar Kamavarapu, Rajakumari Muppavarapu, Ramesh Kankanala. It holds no open charges and ₹36.00 Cr settled loans. Its latest AGM occurred on 26 September 2015, with the balance sheet filed on 31 March 2015. It is based at Plot No. 13B, Jawaharlal Nehru Pharma City, Thanam Parawada, Visakhapatnam, Visakhapatnam, Andhra Pradesh, 531019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232AP2012PTC079367

  • Registration Number

    079367

  • Incorporation Date

    24 February 2012

  • Authorized Capital

    ₹16.00 Cr

  • Paid-Up Capital

    ₹7.34 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 16.00 Cr
  • Paid Up Capital ₹ 7.34 Cr
  • Company Age 13 Year, 11 Months
  • Last Filing with ROC 31 Mar 2015
  • Satisfied Charges ₹ 36.00 Cr
Company report

Siri Drugs India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Siri Drugs India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Siri Drugs India Private Limited?
Current Directors
Name Designation Appointment Date Status
Teena Tummuri Additional Director 17 Oct 2015 Current
Pamidi Ravindra Director 31 Aug 2015 Current
Prasanth Nandigala Director 31 Aug 2015 Current
Mundla Maha Vishnu Director 31 Aug 2015 Current
Hemanth Nandigala Additional Director 17 Oct 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Aug 2015 Past
Pramod Abcsdd Additional Director 31 Aug 2015 Past
Pramod Abcsdd Additional Director 17 Nov 2014 Past
Pramod Abcsdd Additional Director 09 Jun 2014 Past
Pramod Abcsdd Additional Director 26 Sep 2015 Past
Pramod Abcsdd Additional Director 26 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Siri Drugs India.

Enhance accessibility to Siri Drugs India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Siri Drugs India revenue growth over time
Siri Drugs India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Siri Drugs India?

Unlock access to Siri Drugs India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹360,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of Hyderabad : 21.00 Cr
  • Syndicate Bank : 15.00 Cr
Latest Charge Details
Date Lender Amount Status
24 Nov 2014 Syndicate Bank ₹15.00 Cr Satisfied
09 Nov 2013 State Bank Of Hyderabad ₹21.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Siri Drugs India?

Unlock and access historical data on people associated with Siri Drugs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Siri Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siri Drugs India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Siri Drugs India
Recent Activity within the Organization
  • Charges

    A charge registered on 24 Nov 2014 via Charge ID 10540000 with Syndicate Bank was fully satisfied on 03 Nov 2015. was recorded as a recent event.

  • Director Appointment

    The activity Teena Tummuri was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2015 & has been associated with this company since 10 years 4 months . was completed.

  • Director Appointment

    Progress on Hemanth Nandigala was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2015 & has been associated with this company since 10 years 4 months . was documented.

  • Annual General Meeting

    Progress on Siri Drugs India Private Limited last Annual general meeting of members was held on 26 Sep 2015 as per latest MCA records. was documented.

  • Director Appointment

    Pamidi Ravindra was appointed as a Director was appointed as a Director on 31 Aug 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Prasanth Nandigala was appointed as a Director was appointed as a Director on 31 Aug 2015 & has been associated with this company since 10 years 5 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Siri Drugs India Private Limited?

The CIN of Siri Drugs India Private Limited is U24232AP2012PTC079367.

Where is Siri Drugs India Private Limited headquartered?

Siri Drugs India Private Limited is headquartered at Plot No. 13B, Jawaharlal Nehru Pharma City, Thanam Parawada, Visakhapatnam, Visakhapatnam, Andhra Pradesh, 531019.

When was Siri Drugs India Private Limited incorporated?

Siri Drugs India Private Limited was incorporated on 24 February 2012.

Who are the current directors of Siri Drugs India Private Limited?

The current directors of Siri Drugs India Private Limited are

What is the primary industry of Siri Drugs India Private Limited?

The primary industry of Siri Drugs India Private Limited is Pharma.

Is Siri Drugs India Private Limited a listed company?

Siri Drugs India Private Limited is unlisted.

What is the capital structure of Siri Drugs India Private Limited?

The authorized capital of Siri Drugs India Private Limited is ₹16.00 Cr, and the paid-up capital is ₹7.34 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available